v3.26.1
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2025 and 2024:

 

   Level 1   Level 2   Level 3 
   Fair Value Measurements at December 31, 2025 
   Level 1   Level 2   Level 3 
Assets               
Cash  $616,278   $-   $- 
Right-of-use-asset   -    -    1,385,892 
Notes receivable   -    -    - 
Total assets   616,278    -    1,385,892 
Liabilities               
Convertible notes payable, related parties net of $66,587 of discounts   -    -    3,360,691 
Notes payable   -    1,534,500    - 
Notes payable, related parties   -    -    - 
Lease liabilities   -    -    1,704,664 
Total liabilities   -    1,534,500    5,065,355 
Total assets and liabilities  $616,278   $(1,534,500)  $(3,679,463)

 

   Level 1   Level 2   Level 3 
   Fair Value Measurements at December 31, 2024 
   Level 1   Level 2   Level 3 
Assets               
Cash  $2,329,452   $-   $- 
Right-of-use-asset   -    -    1,575,497 
Notes receivable   -    359,982    - 
Total assets   2,329,452    359,982    1,575,497 
Liabilities               
Convertible notes payable, related parties net of $66,587 of discounts   -    -    3,333,413 
Notes payable   -    1,846,147    - 
Notes payable, related parties   -    1,200,000    - 
Lease liability   -    -    1,674,064 
Total liabilities   -    3,046,147    5,077,477 
Total assets and liabilities  $2,329,452   $(2,686,165)  $(3,521,286)